S
ince its introduction in 1971, the Fontan operation has become a mainstay of the palliative strategy for infants born with the heterogeneous collection of congenital heart defects characterized by a functional single ventricle (1, 2) . Over the years, since the initial publications describing this procedure, a number of technical modifications to the surgical strategy have resulted in improved outcomes, allowing generations of children to survive into their adult years (3) (4) (5) . In the current era, perioperative mortality is low, but there remain questions regarding the long-term viability of this man-made circulation (6) .
In this issue of the Journal, Pundi et al. (7) that he has no relationships relevant to the contents of this paper to disclose. Ultimately, the Fontan operation was a paradigmshifting advancement in the care of children born with single-ventricle congenital heart disease.
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Over the years, technical adjustments and improvements in anesthesia and post-operative care have led to substantial improvements in short-and long-term survival as described in the current paper. However, as a community, our work is not done. We need to maintain our focus on ways to improve the efficiency of this circulation to ensure that outcomes continue to improve for future generations.
